HQL · abrdn Life Sciences Investors · Fund Holdings
Market Cap
$527.88M
Shares
30.41M
Volume · Nov 6
37.09K
Avg daily vol (3M)
132.55K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Portfolio holdings reported by registered funds to the SEC on Form N-PORT — the individual securities a fund owns. Only mutual funds, ETFs and closed-end funds file N-PORT, so operating companies show no data.
abrdn Life Sciences Investors
Reported 2026-06-30Net Assets
$689,248,803
Total Assets
$690,887,804
Holdings
158
Filed
2026-08-28
| Holding | CUSIP | Balance | Units | Value | % Net Assets | Category | Country |
|---|---|---|---|---|---|---|---|
| uniQure NV | 000000000 | 564,239 | NS | $25,988,848 | 3.77% | EC | NL |
| Insmed Inc | 457669307 | 208,079 | NS | $22,185,383 | 3.22% | EC | US |
| VeraDermics Inc | 922967104 | 171,383 | NS | $21,069,826 | 3.06% | EC | US |
| Personalis Inc | 71535D106 | 1,542,774 | NS | $20,673,172 | 3.00% | EC | US |
| Argenx SE | 04016X101 | 19,643 | NS | $18,224,186 | 2.64% | EC | NL |
| Dyne Therapeutics Inc | 26818M108 | 799,847 | NS | $17,764,602 | 2.58% | EC | US |
| Denali Therapeutics Inc | 24823R105 | 658,067 | NS | $16,925,483 | 2.46% | EC | US |
| VERADERMICS, INC. | 000000000 | 109,305 | NS | $13,437,957 | 1.95% | EP | US |
| Abivax SA | 00370M103 | 98,044 | NS | $13,065,343 | 1.90% | EC | FR |
| Immunovant Inc | 45258J102 | 337,211 | NS | $12,992,740 | 1.89% | EC | US |
| Tectonic Therapeutic Inc | 878972108 | 370,884 | NS | $12,749,138 | 1.85% | EC | US |
| Crinetics Pharmaceuticals Inc | 22663K107 | 312,153 | NS | $11,680,765 | 1.69% | EC | US |
| Oruka Therapeutics Inc | 687604108 | 122,702 | NS | $11,677,549 | 1.69% | EC | US |
| Equillium Inc | 29446K106 | 3,631,659 | NS | $11,621,309 | 1.69% | EC | US |
| NEUROVANCE MILESTONE INTEREST | 000000000 | 34,055 | NS | $11,413,530 | 1.66% | EC | US |
| Edgewise Therapeutics Inc | 28036F105 | 264,002 | NS | $10,726,401 | 1.56% | EC | US |
| Axsome Therapeutics Inc | 05464T104 | 43,454 | NS | $10,636,236 | 1.54% | EC | US |
| Xenon Pharmaceuticals Inc | 98420N105 | 170,859 | NS | $10,313,049 | 1.50% | EC | CA |
| Taysha Gene Therapies Inc | 877619106 | 1,496,652 | NS | $10,192,200 | 1.48% | EC | US |
| Praxis Precision Medicines Inc | 74006W207 | 30,409 | NS | $10,180,629 | 1.48% | EC | US |
| EyePoint Inc | 30233G209 | 710,173 | NS | $10,155,474 | 1.47% | EC | US |
| Shattuck Labs Inc | 82024L103 | 1,405,851 | NS | $9,756,606 | 1.42% | EC | US |
| Summit Therapeutics Inc | 86627T108 | 630,806 | NS | $9,190,843 | 1.33% | EC | US |
| BioCryst Pharmaceuticals Inc | 09058V103 | 898,336 | NS | $8,983,360 | 1.30% | EC | US |
| Disc Medicine Inc | 254604101 | 121,484 | NS | $8,885,340 | 1.29% | EC | US |
| Structure Therapeutics Inc | 86366E106 | 162,217 | NS | $8,706,186 | 1.26% | EC | KY |
| Precision BioSciences Inc | 74019P207 | 1,085,970 | NS | $8,535,724 | 1.24% | EC | US |
| Arrowhead Pharmaceuticals Inc | 04280A100 | 104,478 | NS | $8,516,002 | 1.24% | EC | US |
| Ionis Pharmaceuticals Inc | 462222100 | 106,455 | NS | $8,440,817 | 1.22% | EC | US |
| Ideaya Biosciences Inc | 45166A102 | 222,056 | NS | $8,276,027 | 1.20% | EC | US |
| Newamsterdam Pharma Co NV | 000000000 | 244,176 | NS | $8,275,125 | 1.20% | EC | NL |
| Revolution Medicines Inc | 76155X100 | 43,763 | NS | $8,195,935 | 1.19% | EC | US |
| Syndax Pharmaceuticals Inc | 87164F105 | 372,766 | NS | $8,148,665 | 1.18% | EC | US |
| Sarepta Therapeutics Inc | 803607100 | 428,795 | NS | $7,705,446 | 1.12% | EC | US |
| Adaptive Biotechnologies Corp | 00650F109 | 344,653 | NS | $7,392,807 | 1.07% | EC | US |
| Vaxcyte Inc | 92243G108 | 126,674 | NS | $7,363,560 | 1.07% | EC | US |
| Tempus AI Inc | 88023B103 | 124,615 | NS | $7,218,947 | 1.05% | EC | US |
| State Street Global Advisors | 857492706 | 6,953,413 | NS | $6,953,413 | 1.01% | STIV | US |
| IMMUNIC | 000000000 | 444,460 | NS | $6,831,356 | 0.99% | DE | US |
| Sagimet Biosciences Inc | 786700104 | 847,700 | NS | $6,552,721 | 0.95% | EC | US |
| Regeneron Pharmaceuticals Inc | 75886F107 | 10,241 | NS | $6,385,673 | 0.93% | EC | US |
| Palvella Therapeutics Inc | 697947109 | 40,805 | NS | $6,235,820 | 0.90% | EC | US |
| Vericel Corp | 92346J108 | 135,240 | NS | $6,016,828 | 0.87% | EC | US |
| Allogene Therapeutics Inc | 019770106 | 2,731,752 | NS | $5,682,044 | 0.82% | EC | US |
| Amgen Inc | 031162100 | 15,306 | NS | $5,542,609 | 0.80% | EC | US |
| Biohaven Ltd | 000000000 | 365,519 | NS | $5,438,923 | 0.79% | EC | VG |
| GRAIL Inc | 384747101 | 77,618 | NS | $5,298,981 | 0.77% | EC | US |
| Codexis Inc | 192005106 | 2,336,234 | NS | $5,279,889 | 0.77% | EC | US |
| ARS Pharmaceuticals Inc | 82835W108 | 651,538 | NS | $5,218,819 | 0.76% | EC | US |
| Amylyx Pharmaceuticals Inc | 03237H101 | 285,776 | NS | $5,132,537 | 0.74% | EC | US |
Showing 1–50 of 158 holdings